These results indicate that LXR inhibition opposes the pro-inflammatory effect of Rheumatoid Arthritis synovial fluid while enhances the expression of genes that mark anti-inflammatory (M-CSF-dependent) macrophages. This evidence concerns the gene CSF1 and rheumatoid arthritis.